Lode Debrabandere
2014
In 2014, Lode Debrabandere earned a total compensation of $1.7M as President and CEO at Osiris Therapeutics, a 237% increase compared to previous year.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $1,171,500 |
| Salary | $360,000 |
| Other | $24,000 |
| Total | $1,705,500 |
Debrabandere received $1.2M in option awards, accounting for 69% of the total pay in 2014.
Debrabandere also received $150K in bonus, $360K in salary and $24K in other compensation.
Rankings
In 2014, Lode Debrabandere's compensation ranked 5,206th out of 13,032 executives tracked by ExecPay. In other words, Debrabandere earned more than 60.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,206 out of 13,032 | 60th |
Division Manufacturing | 1,859 out of 4,966 | 63rd |
Major group Chemicals And Allied Products | 621 out of 1,686 | 63rd |
Industry group Drugs | 473 out of 1,365 | 65th |
Industry Biological Products, Except Diagnostic Substances | 79 out of 236 | 67th |
Source: SEC filing on April 30, 2015.
Debrabandere's colleagues
We found four more compensation records of executives who worked with Lode Debrabandere at Osiris Therapeutics in 2014.